Metabolic Syndrome and Insulin Resistance by HOMA-IR in Menopause

Abstract Background: Metabolic syndrome is an important cardiovascular risk factor, and its prevalence increases after menopause. However, it is still uncertain whether menopause is an independent risk factor for metabolic syndrome. One of the pathophysiological basis for metabolic syndrome is insulin resistance, which can be calculated by the Homeostatic Model Assessment-Insulin Resistance (HOMA-IR) method, and the association between insulin resistance and menopause is little known. Objective: To evaluate the association between metabolic syndrome and insulin resistance in menopausal women. Method: Descriptive study, which evaluated 150 women, aged 40 to 65, treated at a Gynecology Outpatient Clinic of a tertiary public hospital, from May to December of 2013. The sample was divided into two groups: Group I, comprising women in the premenopausal period and Group II, comprising women in the post-menopausal period. The presence of metabolic syndrome and its components were evaluated, as well as occurrence of insulin resistance in both groups. The association of menopausal status and the assessed variables was assessed using the Mann-Whitney, Chi-square and Fisher's exact tests. The significance level was set at 5%. The statistical analysis was performed using STATA 12.0. Results: Metabolic syndrome and its components were more prevalent in postmenopausal women. Postmenopausal women also had a higher prevalence of insulin resistance, but no statistical association was observed between the findings. Conclusion: The menopausal status was not significantly associated with metabolic syndrome and insulin resistance. Insulin resistance was considered an independent risk factor for the development of metabolic syndrome only in the postmenopausal group.

Saved in:
Bibliographic Details
Main Authors: Fonseca,Érika Joseth Nogueira da Cruz, Rocha,Tânia Pavão Oliveira, Nogueira,Iara Antônia Lustosa, Melo,Jorgileia Braga de, Silva,Bianca Lima e, Lopes,Elenice Jardim, Serra,Claudiana Batalha, Andrade,Maria Vaneide Gomes, Sousa,Surama Maria Bandeira de, Figueredo Neto,José Albuquerque de
Format: Digital revista
Language:English
Published: Sociedade Brasileira de Cardiologia 2018
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2359-56472018000300201
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S2359-56472018000300201
record_format ojs
spelling oai:scielo:S2359-564720180003002012018-05-29Metabolic Syndrome and Insulin Resistance by HOMA-IR in MenopauseFonseca,Érika Joseth Nogueira da CruzRocha,Tânia Pavão OliveiraNogueira,Iara Antônia LustosaMelo,Jorgileia Braga deSilva,Bianca Lima eLopes,Elenice JardimSerra,Claudiana BatalhaAndrade,Maria Vaneide GomesSousa,Surama Maria Bandeira deFigueredo Neto,José Albuquerque de Metabolic Syndrome Insulin Resistance Menopause Climacteric Cardiovascular Diseases Abstract Background: Metabolic syndrome is an important cardiovascular risk factor, and its prevalence increases after menopause. However, it is still uncertain whether menopause is an independent risk factor for metabolic syndrome. One of the pathophysiological basis for metabolic syndrome is insulin resistance, which can be calculated by the Homeostatic Model Assessment-Insulin Resistance (HOMA-IR) method, and the association between insulin resistance and menopause is little known. Objective: To evaluate the association between metabolic syndrome and insulin resistance in menopausal women. Method: Descriptive study, which evaluated 150 women, aged 40 to 65, treated at a Gynecology Outpatient Clinic of a tertiary public hospital, from May to December of 2013. The sample was divided into two groups: Group I, comprising women in the premenopausal period and Group II, comprising women in the post-menopausal period. The presence of metabolic syndrome and its components were evaluated, as well as occurrence of insulin resistance in both groups. The association of menopausal status and the assessed variables was assessed using the Mann-Whitney, Chi-square and Fisher's exact tests. The significance level was set at 5%. The statistical analysis was performed using STATA 12.0. Results: Metabolic syndrome and its components were more prevalent in postmenopausal women. Postmenopausal women also had a higher prevalence of insulin resistance, but no statistical association was observed between the findings. Conclusion: The menopausal status was not significantly associated with metabolic syndrome and insulin resistance. Insulin resistance was considered an independent risk factor for the development of metabolic syndrome only in the postmenopausal group.info:eu-repo/semantics/openAccessSociedade Brasileira de CardiologiaInternational Journal of Cardiovascular Sciences v.31 n.3 20182018-05-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S2359-56472018000300201en10.5935/2359-4802.20180009
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Fonseca,Érika Joseth Nogueira da Cruz
Rocha,Tânia Pavão Oliveira
Nogueira,Iara Antônia Lustosa
Melo,Jorgileia Braga de
Silva,Bianca Lima e
Lopes,Elenice Jardim
Serra,Claudiana Batalha
Andrade,Maria Vaneide Gomes
Sousa,Surama Maria Bandeira de
Figueredo Neto,José Albuquerque de
spellingShingle Fonseca,Érika Joseth Nogueira da Cruz
Rocha,Tânia Pavão Oliveira
Nogueira,Iara Antônia Lustosa
Melo,Jorgileia Braga de
Silva,Bianca Lima e
Lopes,Elenice Jardim
Serra,Claudiana Batalha
Andrade,Maria Vaneide Gomes
Sousa,Surama Maria Bandeira de
Figueredo Neto,José Albuquerque de
Metabolic Syndrome and Insulin Resistance by HOMA-IR in Menopause
author_facet Fonseca,Érika Joseth Nogueira da Cruz
Rocha,Tânia Pavão Oliveira
Nogueira,Iara Antônia Lustosa
Melo,Jorgileia Braga de
Silva,Bianca Lima e
Lopes,Elenice Jardim
Serra,Claudiana Batalha
Andrade,Maria Vaneide Gomes
Sousa,Surama Maria Bandeira de
Figueredo Neto,José Albuquerque de
author_sort Fonseca,Érika Joseth Nogueira da Cruz
title Metabolic Syndrome and Insulin Resistance by HOMA-IR in Menopause
title_short Metabolic Syndrome and Insulin Resistance by HOMA-IR in Menopause
title_full Metabolic Syndrome and Insulin Resistance by HOMA-IR in Menopause
title_fullStr Metabolic Syndrome and Insulin Resistance by HOMA-IR in Menopause
title_full_unstemmed Metabolic Syndrome and Insulin Resistance by HOMA-IR in Menopause
title_sort metabolic syndrome and insulin resistance by homa-ir in menopause
description Abstract Background: Metabolic syndrome is an important cardiovascular risk factor, and its prevalence increases after menopause. However, it is still uncertain whether menopause is an independent risk factor for metabolic syndrome. One of the pathophysiological basis for metabolic syndrome is insulin resistance, which can be calculated by the Homeostatic Model Assessment-Insulin Resistance (HOMA-IR) method, and the association between insulin resistance and menopause is little known. Objective: To evaluate the association between metabolic syndrome and insulin resistance in menopausal women. Method: Descriptive study, which evaluated 150 women, aged 40 to 65, treated at a Gynecology Outpatient Clinic of a tertiary public hospital, from May to December of 2013. The sample was divided into two groups: Group I, comprising women in the premenopausal period and Group II, comprising women in the post-menopausal period. The presence of metabolic syndrome and its components were evaluated, as well as occurrence of insulin resistance in both groups. The association of menopausal status and the assessed variables was assessed using the Mann-Whitney, Chi-square and Fisher's exact tests. The significance level was set at 5%. The statistical analysis was performed using STATA 12.0. Results: Metabolic syndrome and its components were more prevalent in postmenopausal women. Postmenopausal women also had a higher prevalence of insulin resistance, but no statistical association was observed between the findings. Conclusion: The menopausal status was not significantly associated with metabolic syndrome and insulin resistance. Insulin resistance was considered an independent risk factor for the development of metabolic syndrome only in the postmenopausal group.
publisher Sociedade Brasileira de Cardiologia
publishDate 2018
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2359-56472018000300201
work_keys_str_mv AT fonsecaerikajosethnogueiradacruz metabolicsyndromeandinsulinresistancebyhomairinmenopause
AT rochataniapavaooliveira metabolicsyndromeandinsulinresistancebyhomairinmenopause
AT nogueiraiaraantonialustosa metabolicsyndromeandinsulinresistancebyhomairinmenopause
AT melojorgileiabragade metabolicsyndromeandinsulinresistancebyhomairinmenopause
AT silvabiancalimae metabolicsyndromeandinsulinresistancebyhomairinmenopause
AT lopeselenicejardim metabolicsyndromeandinsulinresistancebyhomairinmenopause
AT serraclaudianabatalha metabolicsyndromeandinsulinresistancebyhomairinmenopause
AT andrademariavaneidegomes metabolicsyndromeandinsulinresistancebyhomairinmenopause
AT sousasuramamariabandeirade metabolicsyndromeandinsulinresistancebyhomairinmenopause
AT figueredonetojosealbuquerquede metabolicsyndromeandinsulinresistancebyhomairinmenopause
_version_ 1756441567121375232